Our study mainly applied RNAi technology with the aim of blocking the two signaling pathways. PD-1/PD-L1and CTLA-4/CD80, /CD86 were used to enhance the activity of T cells to inhibit the growth of tumor cells. This evidence concerns the gene CTLA4 and neoplasm.